Stemline Therapeutics, Inc. EPS - Earnings per Share 2013-2020 | STML
Stemline Therapeutics, Inc. eps - earnings per share from 2013 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Stemline Therapeutics, Inc. Annual EPS |
| 2019 |
$-1.83 |
| 2018 |
$-2.99 |
| 2017 |
$-2.94 |
| 2016 |
$-2.15 |
| 2015 |
$-2.15 |
| 2014 |
$-2.23 |
| 2013 |
$-2.35 |
| 2012 |
$-1.82 |
| 2011 |
$-0.80 |
| 2010 |
$2.81 |
| 2009 |
$-1.02 |
| Stemline Therapeutics, Inc. Quarterly EPS |
| 2020-03-31 |
$-0.45 |
| 2019-12-31 |
$-0.34 |
| 2019-09-30 |
$-0.34 |
| 2019-06-30 |
$-0.42 |
| 2019-03-31 |
$-0.73 |
| 2018-12-31 |
$-0.91 |
| 2018-09-30 |
$-0.73 |
| 2018-06-30 |
$-0.66 |
| 2018-03-31 |
$-0.69 |
| 2017-12-31 |
$-0.93 |
| 2017-09-30 |
$-0.68 |
| 2017-06-30 |
$-0.66 |
| 2017-03-31 |
$-0.67 |
| 2016-12-31 |
$-0.56 |
| 2016-09-30 |
$-0.56 |
| 2016-06-30 |
$-0.52 |
| 2016-03-31 |
$-0.51 |
| 2015-12-31 |
$-0.58 |
| 2015-09-30 |
$-0.53 |
| 2015-06-30 |
$-0.58 |
| 2015-03-31 |
$-0.46 |
| 2014-12-31 |
$-0.53 |
| 2014-09-30 |
$-0.53 |
| 2014-06-30 |
$-0.47 |
| 2014-03-31 |
$-0.70 |
| 2013-12-31 |
$-0.45 |
| 2013-09-30 |
$-0.45 |
| 2013-06-30 |
$-0.55 |
| 2013-03-31 |
$-0.90 |
| 2012-12-31 |
$-0.38 |
| 2012-09-30 |
$-0.56 |
| 2012-06-30 |
$-0.54 |
| 2012-03-31 |
$-0.34 |
